Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/135882
Title: TARGETING THE PIK3 PATHWAY IN NON-SMALL CELL LUNG CANCER
Authors: DANIEL TAN SHAO WENG
Keywords: PI3K pathway, EGFR mutant NSCLC, TKI resistance
Issue Date: 1-Jun-2016
Citation: DANIEL TAN SHAO WENG (2016-06-01). TARGETING THE PIK3 PATHWAY IN NON-SMALL CELL LUNG CANCER. ScholarBank@NUS Repository.
Abstract: The phosphotidyl inositol (3) kinase (PI3K) pathway is a critical survival pathway that is subverted in many cancers, particularly those that are receptor tyrosine kinase driven. This thesis describes a multi-pronged approach to examine the relevance of this pathway in epidermal growth factor receptor mutation positive lung adenocarcinoma, the commonest subtype in Singapore. I used a combination of integrative genomics and other molecular assays to describe the prevalence of PI3K pathway alterations in our local population (Tan, IJC 2014). I further evaluated the role of PI3K inhibition in the clinic, gaining significant insights to the challenges in developing this class of compounds (Tan, ASCO Proceedings 2014), and generated a range of preclinical models to inform on the potential therapeutic niches. Finally, with expanding knowledge on intra-tumoral heterogeneity, I present the case for high precision genomic interrogation, in order to delineate mutational context to predict therapeutic vulnerabilities (Tan, WCLC 2015).
URI: http://scholarbank.nus.edu.sg/handle/10635/135882
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
TanDSW_PhDThesis.pdf18.31 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

164
checked on Dec 1, 2022

Download(s)

54
checked on Dec 1, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.